Stock SPRINT SPRINT BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Delayed Nasdaq Stockholm
Other stock markets
 05:10:15 2024-05-29 EDT 		5-day change 1st Jan Change
1.238 SEK +2.15% Intraday chart for Sprint Bioscience AB -5.21% -28.65%
05-08 Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-14 Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sprint Bioscience - Improved sales and activity
AQ
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Positive preclinical results in Sprint Bioscience's oncology program targeting TREX1
AQ
New data from the VPS34 program published
AQ
Sprint Bioscience participates in a delegation trip to Washington DC
AQ
Sprint Bioscience Q4 2023 - A major step towards break-even
AQ
Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Sprint Bioscience’s DISA program further validated in two recent scientific publications
AQ
Sprint Bioscience - Replacing Decipher as a VPS34 partner
AQ
Sprint Bioscience - Easing pressure and a sharper focus on value drivers
AQ
Sprint Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Sprint Bioscience - New beginnings
AQ
Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Sprint Bioscience licenses the VADA (VRK1) program to Day One Biopharmaceuticals
AQ
Sprint Bioscience Licenses the Vada Program to Day One Biopharmaceuticals
CI
Sprint Bioscience Q1 2023 - VADA deal needed
AQ
Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Sprint Bioscience presents preclinical data from the DISA program at research conference
AQ
Sprint Bioscience Q4 2022 - Temporary setbacks
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPRINT Stock
  4. News Sprint Bioscience AB